Xenon: The Future Anaesthetic Agent

Journal Title: Indian Journal of Anesthesia and Analgesia - Year 2018, Vol 5, Issue 3

Abstract

After the discovery of xenon in 1898, xenon anaesthesia has been studied for decades. The search for an inert gas to replace N2O led to introduction of xenon in anaesthesia practice. Xenon’s anaesthetic properties were discovered in 1939. Since then, a number of studies of xenon anaesthesia have been conducted. The anaesthetic properties of xenon is mainly conferred by the inhibition of N-methyl-D-aspartate receptors in the central nervous system. Xenon is an inert gas and, theoretically, is not metabolized to toxic metabolites, does not react with absorbent, and does not deplete vitamin B12, as opposed to other inhaled agents. Xenon is described as having many of the characteristics of an ideal inhalational anaesthetic agent, including rapid induction and emergence, analgesic properties, cardiovascular stability, and neuroprotective qualities. It is non-flammable, non-explosive, non-toxic, devoid of teratogenic effects and does not contribute to the greenhouse effect. Clinically, there are certain disadvantages to xenon anaesthesia. Because of its high density, xenon was found to increase airway resistance and work of breathing in an animal study. Nevertheless, it may be a good choice for high-risk patients with unstable haemodynamics, cardiovascular diseases, expected prolonged recovery from anaesthesia, or advanced age. Moreover, the high cost of xenon associated with its production has discouraged more widespread use. This article reviews the benefits and drawbacks of xenon anaesthesia, and discusses future perspectives.

Authors and Affiliations

Mukesh Somvanshi

Keywords

Related Articles

Effects of Intravenous Ondansetron and Granisetron on Hemodynamic Changes and Blockade Characterestics Induced By Spinal Anesthesia: A Prospective Observational Study

Background: Spinal anaesthesia has many advantages for elective surgeries, but the undesired effect of hypotension is to be managed by different interventions. Induction of the Bezold Jarisch reflex in the setting of d...

Effect of Intrathecal Dexmedetomidine with Hyperbaric Bupivacaine Administered as Mixture and Sequentially in Lower Abdominal Procedures

Objectives: To compare the effects of intrathecal dexmedetomidine given mixed or sequential with 0.5% hyperbaric bupivacaine for spinal anaesthesia. Method: 60 patients posted for elective lower abdominal procedures were...

Prospective Study of Dexmedetomidine-Propofol versus Dexmedetomidine-Ketamine for Sedation and Anesthesia in Hysteroscopic Examination and Procedures

Context: Dexmedetomidine a wonderful drug with vital organ protective properties. When combined with other intravenous anaesthetic agents useful in surgical procedure without intubation. Less research work was done on th...

A Comparative Study: Ultrasound Guided Transverse Abdominis Plane Block versus Caudal Block in Paediatric Patients for Lower Abdominal Surgeries

Background: Paediatric patients undergoing lower abdominal surgeries require adequate pain relief peri operatively, which is often neglected. Various methods of pain relief in paediatric patients are systemic opioids, NS...

Four Segments Versus two Segments Paravertebral Block for Inguinal Hernia Repair

Background: Paravertebral block (PVB) has been successfully used to provide good analgesia with fewer side effects in inguinal herniorrhaphy. So, the present study was conducted to compare the characteristics of two segm...

Download PDF file
  • EP ID EP535224
  • DOI 10.21088/ijaa.2349.8471.5318.23
  • Views 77
  • Downloads 0

How To Cite

Mukesh Somvanshi (2018). Xenon: The Future Anaesthetic Agent. Indian Journal of Anesthesia and Analgesia, 5(3), 492-499. https://europub.co.uk/articles/-A-535224